153 related articles for article (PubMed ID: 12094475)
41. Morphologic, immunophenotypic, and molecular evaluation of bone marrow involvement in non-Hodgkin's lymphoma.
Crotty PL; Smith BR; Tallini G
Diagn Mol Pathol; 1998 Apr; 7(2):90-5. PubMed ID: 9785007
[TBL] [Abstract][Full Text] [Related]
42. Lymphoproliferative Diseases of the Gut: A Survival Guide for the General Pathologist.
Owens SR
Surg Pathol Clin; 2017 Dec; 10(4):1021-1037. PubMed ID: 29103531
[TBL] [Abstract][Full Text] [Related]
43. Holding on to the Matutes score while dropping FMC7: new opportunity from standardised approaches in multiparameter flow cytometry.
Zhu J; Raimbault A; Sourdeau E; Maillon A; Mathis S; Capron C; Lemaire P; Ronez E; Moatti H; Jondeau K; Clauser S; Bardet V
Br J Haematol; 2020 Aug; 190(4):e255-e258. PubMed ID: 32557566
[No Abstract] [Full Text] [Related]
44. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
Rothe G; Schmitz G
Leukemia; 1996 May; 10(5):877-95. PubMed ID: 8656686
[TBL] [Abstract][Full Text] [Related]
45. Flow cytometric analysis of lymphomas and lymphoproliferative disorders.
Stetler-Stevenson M; Braylan RC
Semin Hematol; 2001 Apr; 38(2):111-23. PubMed ID: 11309693
[TBL] [Abstract][Full Text] [Related]
46. T cell-rich lymphoid infiltrates with large B cells: a review of key entities and diagnostic approach.
Cheng CL; O'Connor S
J Clin Pathol; 2017 Mar; 70(3):187-201. PubMed ID: 27895166
[TBL] [Abstract][Full Text] [Related]
47. [T gamma-lymphocytosis: a lymphoproliferative disease or reactive state].
Zaritskiĭ AIu; Pozniak EI; Tsveĭbakh AS; Simbirtseva NIu; Ivasenko IN
Vopr Onkol; 1986; 32(4):11-25. PubMed ID: 3518236
[No Abstract] [Full Text] [Related]
48. Molecular and flow cytometry characterization during the follow-up of three simultaneous lymphoproliferative disorders: hairy cell leukemia, monoclonal B-cell lymphocytosis, and CD4(++) /CD8(+/- dim) T-large granular lymphocytosis--a case report.
Garrido P; Jiménez P; Sánchez C; Valero F; Balanzategui A; Almagro M; López P; de Pablos JM; Navarro P; Cabrera A; González M; Jurado M; Ruiz-Cabello F
Cytometry B Clin Cytom; 2011 May; 80(3):195-200. PubMed ID: 21520406
[TBL] [Abstract][Full Text] [Related]
49. Two-color flow cytometry with a CD19 gate for the evaluation of bone marrow involvement of B-cell lymphoma.
Kawano-Yamamoto C; Muroi K; Izumi T; Saito K; Ozawa K
Leuk Lymphoma; 2002 Nov; 43(11):2133-7. PubMed ID: 12533038
[TBL] [Abstract][Full Text] [Related]
50. Morphologic, flow cytometric and cytogenetic evaluation of bone marrow involvement in B-cell lymphoma.
Gomyo H; Shimoyama M; Minagawa K; Yakushijin K; Urahama N; Okamura A; Yamamoto K; Ito M; Chihara K; Hayashi Y; Matsui T
Haematologica; 2003 Dec; 88(12):1358-65. PubMed ID: 14687988
[TBL] [Abstract][Full Text] [Related]
51. [Problems of classification of lymphoproliferative disorders].
Bokarev IN; Khusainov VM
Klin Med (Mosk); 1991 Apr; 69(4):3-7. PubMed ID: 1865645
[No Abstract] [Full Text] [Related]
52. Characteristics of Lymphoproliferative Disorders with More Than One Aberrant Cell Population as Detected by 10-Color Flow Cytometry.
Mahdi T; Rajab A; Padmore R; Porwit A
Cytometry B Clin Cytom; 2018 Mar; 94(2):230-238. PubMed ID: 27438095
[TBL] [Abstract][Full Text] [Related]
53. Selected case studies in hematopathology: application of current ancillary techniques in diagnosis.
Reddy VV
Adv Exp Med Biol; 2005; 563():112-24. PubMed ID: 16433127
[No Abstract] [Full Text] [Related]
54. Clonality assessment of lymphoproliferative disorders by multiparameter flow cytometry of paraffin-embedded tissue: an additional diagnostic tool in surgical pathology.
Leers MP; Theunissen PH; Ramaekers FC; Schutte B; Nap M
Hum Pathol; 2000 Apr; 31(4):422-7. PubMed ID: 10821487
[TBL] [Abstract][Full Text] [Related]
55. Fine-needle cytology and flow cytometry assessment of reactive and lymphoproliferative processes of the breast.
Vigliar E; Cozzolino I; Fernandez LV; Di Pietto L; Riccardi A; Picardi M; Pane F; Vetrani A; Troncone G; Zeppa P
Acta Cytol; 2012; 56(2):130-8. PubMed ID: 22378074
[TBL] [Abstract][Full Text] [Related]
56. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
57. "T-cell-rich B-cell lymphoproliferative disorder" of the bone marrow.
Aboul-Nasr R; O'Brien S; Freireich EJ; Ginsberg CF; Kantarjian HM; Koller CA; Keating MJ; Albitar M
Leuk Lymphoma; 2001; 42(5):1023-31. PubMed ID: 11697619
[TBL] [Abstract][Full Text] [Related]
58. Chemokine receptor expression in B-cell lymphoproliferative disorders.
Wong S; Fulcher D
Leuk Lymphoma; 2004 Dec; 45(12):2491-6. PubMed ID: 15621766
[TBL] [Abstract][Full Text] [Related]
59. Fine-needle aspiration biopsy for the primary diagnosis of lymphoproliferative disorders involving the spleen: one institution's experience and review of the literature.
Ramdall RB; Cai G; Alasio TM; Levine P
Diagn Cytopathol; 2006 Dec; 34(12):812-7. PubMed ID: 17115435
[TBL] [Abstract][Full Text] [Related]
60. [Immunophenotyping of B chronic lymphoproliferative syndromes (CLL excluded): confrontation with the histology].
El Borgi W; Ben Salah N; Ben Lakhal F; Makni L; Gouider E; Hafsia R
Ann Biol Clin (Paris); 2013; 71(6):693-7. PubMed ID: 24342790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
